Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
3.800
+0.050 (1.33%)
At close: May 7, 2026
Market Cap96.94M +121.3%
Revenue (ttm)34.70M +22.9%
Net Income7.22M +102.1%
EPS0.20 +102.1%
Shares Out36.00M
PE Ratio13.43
Forward PEn/a
Dividend0.05 (2.00%)
Ex-Dividend DateApr 16, 2026
Volume4,329
Average Volume16,069
Open3.730
Previous Close3.750
Day's Range3.730 - 3.800
52-Week Range1.850 - 4.000
Beta0.46
RSI71.04
Earnings DateApr 15, 2026

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. The company offers over the counter, prescription pharmaceutical, and nutritional supplements products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions. It also provides medical devices... [Read more]

Industry Pharmaceutical Preparations
Founded 1969
Employees 595
Stock Exchange Palestine Stock Exchange
Ticker Symbol JPH
Full Company Profile

Financial Performance

In 2025, Jerusalem Pharmaceuticals's revenue was $48.95 million, an increase of 22.91% compared to the previous year's $39.82 million. Earnings were $10.18 million, an increase of 102.13%.

Financial numbers in USD Financial Statements